XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Identifiable Intangible Assets and Goodwill - Schedule of Finite-lived and Indefinite-lived Intangible Assets (Detail) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount $ 103,959 $ 102,944
Finite-lived intangible assets, accumulated amortization [1] (65,365) (62,828)
Finite-lived intangible assets, net 38,594 40,116
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 22,646 24,784
Intangible assets, gross carrying amount [1] 126,605 127,728
Finite-lived intangible assets, accumulated amortization [1] (65,365) (62,828)
Identifiable Intangible Assets, less Accumulated Amortization [1] 61,240 64,900
Brands [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [2] 0 827
IPR&D [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [3] 21,976 23,193
License Agreements and Other [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 670 763
Developed technology rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount [4] 99,449 99,267
Finite-lived intangible assets, accumulated amortization [4] (62,905) (60,493)
Finite-lived intangible assets, net [4] 36,543 38,773
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization [4] (62,905) (60,493)
Brands [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount [2] 1,749 922
Finite-lived intangible assets, accumulated amortization [2] (933) (877)
Finite-lived intangible assets, net [2] 816 45
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization [2] (933) (877)
License Agreements and Other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount 2,761 2,756
Finite-lived intangible assets, accumulated amortization (1,527) (1,458)
Finite-lived intangible assets, net 1,234 1,297
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization $ (1,527) $ (1,458)
[1] The decrease is primarily due to amortization expense of $2.6 billion, measurement period adjustments related to our acquisition of Seagen of $625 million (see Note 2A) and impairments of $349 million (see Note 4).
[2] The changes in the gross carrying amounts reflect the transfer of $827 million from indefinite-lived brands to finite-lived brands for Depo-Medrol.
[3] The decrease in the gross carrying amount reflects the transfer of IPR&D to developed technology rights of $727 million for talazoparib (Talzenna), $250 million of measurement period adjustments related to our acquisition of Seagen (see Note 2A) and impairments of $240 million (see Note 4).
[4] The increase in the gross carrying amount includes the transfer of IPR&D to developed technology rights of $727 million for talazoparib (Talzenna), partially offset by $385 million of measurement period adjustments related to our acquisition of Seagen (see Note 2A) and impairments of $109 million (see Note 4).